Stocks
ImmunoGen (IMGN) EBITDA margin US GAAP (year values) |
|||||||||
| 2018 | 2019 | 2020 | 2021 | 2022 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -285.1% | -79.9% | -14.9% | -200.0% | -200.0% | 14.4% | ||
| Changes by years, y/y, % | -222pp | +205pp | +65pp | -185pp | 0pp | +25.8% | |||
ImmunoGen. EBITDA margin, %
ImmunoGen. EBITDA margin, changes, pp
ImmunoGen (IMGN) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q4 | 2023Q2 | 2023Q3 | 2024Q1 | LTM ? | |||
| EBITDA margin, % | ? | -80.5% | -2.76% | -2.76% | 27.0% | 27.0% | 14.4% | |
| Changes by years, y/y, % | -22pp | +135pp | +428pp | +534pp | +108pp | |||
| Changes by quarters, q/q, % | -108pp | +78pp | 0pp | +30pp | 0pp | |||
